25 results
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
15 Mar 22
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Results
4:04pm
in the fourth quarter of 2020.
R&D expense for the fourth quarter of 2021 was $4.9 million compared to $2.2 million in the fourth quarter of 2020.
Net
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
9 Nov 21
Surgalign Holdings, Inc. Announces Third Quarter 2021 Results
4:03pm
million in the third quarter of 2020.
R&D expense for the third quarter of 2021 was $2.9 million compared to $2.2 million in the third quarter of 2020
8-K
EX-99.1
qxe6w
6 Aug 21
Surgalign Holdings, Inc. Announces Second Quarter 2021 Results
8:31am
8-K
EX-99.1
vu4eflqpsx7 r4
10 May 21
Surgalign Holdings, Inc. Announces First Quarter 2021 Results
4:16pm
8-K
EX-99.1
xzudd rdcp
16 Mar 21
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2020 Results and Introduces 2021 Guidance
4:08pm
424B4
abw b6cqbjjcn0p76
29 Jan 21
Prospectus supplement with pricing info
12:00am
S-1/A
q1si sejzghynkyq
25 Jan 21
IPO registration (amended)
5:10pm
S-1
j4pedoaepjkcody sg
30 Dec 20
IPO registration
5:08pm
8-K/A
EX-99.2
igbzj6mn99idpd0
12 Nov 20
Results of Operations and Financial Condition
4:37pm
8-K
EX-99.1
sm1k9sn
12 Nov 20
Regulation FD Disclosure
12:32pm
8-K
EX-99.1
jd7twvjw2z bm2
23 Oct 20
Completion of Acquisition or Disposition of Assets
12:28pm
8-K
EX-99.1
jt5n t6bdgw
11 Jun 20
Other Events
5:03pm
DEFA14A
EX-99.1
f9dz cljtbmv2wmyttb
11 Jun 20
Additional proxy soliciting materials
5:02pm
10-K/A
utppoav7stzj2b3 hyy
8 Jun 20
Annual report (amended)
6:14am
8-K
EX-99.2
35zzbhqqe oz304b6k3
15 Jan 20
RTI Surgical Holdings, Inc.® Announces Sale of OEM Business and Preliminary Fourth Quarter and Full Year 2019 Revenues
4:19pm